The long-term outcome of patients with hypertensive cardiomyopathy

Journal of Human Hypertension

Volumn 19, Issue 5, 2005, Pages 393-400

  de Carvalho Frimm, C ^a   Soufen, H N ^a   Koike, M K ^a   Pereira, V F A ^a   Curi M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiomyopathy; Outcome

Indexed keywords

CAPTOPRIL; CREATININE; DIGOXIN; DIPYRIDAMOLE; ENALAPRIL; HYDRALAZINE; HYDROCHLOROTHIAZIDE; METHYLDOPA; SPIRONOLACTONE;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CONFIDENCE INTERVAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DISEASE; HEART LEFT VENTRICLE MASS; HEART MUSCLE PERFUSION; HUMAN; HYPERTENSION; IMAGING SYSTEM; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; VARIANCE;

BLOOD PRESSURE; BODY MASS INDEX; CARDIOMYOPATHY, DILATED; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 18644371193     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001836     Document Type: Article

References (41)

1. Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med 1983; 75: 4-11.
2. Casale PN et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173-178.
3. Kannel WB. Vital epidemiologic clues in heart failure. J Clin Epidemiol 2000; 53: 229-235.
4. Felker GM et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000; 342: 1077-1084.
5. Alla F et al. Differential clinical prognostic classifications in dilated and ischemic advanced heart failure: the EPICAL study. Am Heart J 2000; 139: 895-904.
6. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressure averaging 115 through 129 mmHg. JAMA 1967; 202: 1028-1034.
7. Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996; 27: 1214-1218.
8. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The commitee on M-mode standardization of the American Society of Echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
9. Troy BL, Pombo J, Rackley CE. Measurement of left ventricular wall stress and mass by echocardiography. Circulation 1972; 45: 602-611.
10. Fortuin NJ, Hood Jr WP, Craige E. Evaluation of left ventricular function by echocardiography. Circulation 1972; 46: 26-35.
11. Pombo JF, Troy BL, Russell Jr RO. Left ventricular volumes and ejection fraction by echocardiography. Circulation 1971; 43: 480-490.
12. Levy D et al. The progression of hypertension to congestive heart failure. JAMA 1996; 275: 1557-1562.
13. Anguita M et al. [Heart failure caused by severe systolic ventricular dysfunction of hypertensive origin. Long-term clinical and functional course]. Rev Esp Cardiol 2000; 53: 927-931.
14. Brown DW, Giles WH, Croft JB. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. Am Heart J 2000; 140: 848-856.
15. Sundstrom J et al. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation 2001; 103: 2346-2351.
16. Frimm CD et al. Left ventricular hypertrophy predicts outcome of hypertension regardless of the type of ventricular arrhythmia present. J Hum Hypertens 1999; 13: 617-623.
17. Frimm CD et al. Normalization of left ventricular dysfunction in systemic hypertension. Clin Cardiol 2000; 23: 443-448.
18. Cohn JN et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303-310.
19. Lechat P et al. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). Circulation 1997; 96: 2197-2205.
20. Yurenev AP et al. Management of essential hypertension in patients with different degrees of left ventricular hypertrophy. Multicenter trial. Am J Hypertens 1992; 5: 182S-189S.
21. Verdecchia P et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998; 97: 48-54.
22. Cipriano C et al. Prognostic value of left ventricular mass and its evolution during treatment in the Bordeaux cohort of hypertensive patients. Am J Hypertens 2001; 14: 524-529.
23. Kenchaiah S et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305-313.
24. Stevens J et al. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998; 338: 1-7.
25. Dwyer EM, Asif M, Ippolito T, Gillespie M. Role of hypertension, diabetes, obesity, and race in the development of symptomatic myocardial dysfunction in a predominantly minority population with normal coronary arteries. Am Heart J 2000; 139: 297-304.
26. Blake J et al. Relation of obesity, high sodium intake, and eccentric left ventricular hypertrophy to left ventricular exercise dysfunction in essential hypertension. Am J Med 1990; 88: 477-485.
27. Pascual M et al. Effects of isolated obesity on systolic and diastolic left ventricular function. Heart 2003; 89: 1152-1156.
28. Davos CH et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 2003; 9: 29-35.
29. Anker SD et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003; 361: 1077-1083.
30. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 2004; 43: 1439-1444.
31. Juilliere Y et al. Dilated cardiomyopathy: long-term follow-up and predictors of survival. Int J Cardiol 1988; 21: 269-277.
32. Marmor A, Schneeweiss A. Prognostic value of non-invasively obtained left ventricular contractile reserve in patients with severe heart failure. J Am Coll Cardiol 1997; 29: 422-428.
33. Philbin EF et al. Race-related differences among patients with left ventricular dysfunction: observations from a biracial angiographic cohort. Harlem-Bassett LP(A) Investigators. J Card Fail 2000; 6: 187-193.
34. Frohlich ED. The sixth report of the Joint National Committee: an appropriate celebration of the 25th anniversary of the National High Blood Pressure Education Program. Hypertension 1997; 30: 1305-1306.
35. Yancy CW, Laskar S, Eichhorn E. The use of beta-adrenergic receptor antagonists in the treatment of African Americans with heart failure. Congest Heart Fail 2004; 10: 34-37.
36. Badano LP et al. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction. J Am Soc Echocardiogr 2004; 17: 253-261.
37. Philbin EF et al. Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 2000; 109: 605-613.
38. Morales FJ et al. Deceleration time of early filling in patients with left ventricular systolic dysfunction: functional and prognostic independent value. Am Heart J 2002; 143: 1101-1106.
39. Hansen A et al. Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure. J Am Coll Cardiol 2001; 37: 1049-1055.
40. Dini FL et al. Impact of blunted pulmonary venous flow on the outcome of patients with left ventricular systolic dysfunction secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2000; 85: 1455-1460.
41. Yamamoto T et al. Prognostic value of the atrial systolic mitral annular motion velocity in patients with left ventricular systolic dysfunction. J Am Soc Echocardiogr 2003; 16: 333-339.